Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
| ▸ | MGLL | Q99685 | 1/20 | 0.37 |
| ▸ | HEXA | P06865 | 1/20 | 0.36 |
| ▸ | HEXB | P07686 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.35 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4375825 | 0.84 | ALDH1A1 (0.50) | KMT2AMEN1POLBKDM4EFAAH | |
| SCHEMBL10541131 | 0.84 | KMT2A (0.33) | KMT2AMEN1POLBKDM4EHEXA | |
| SCHEMBL16039334 | 0.82 | ALDH1A1 (0.48) | KMT2AMEN1POLBKDM4EFAAH | |
| SCHEMBL8863095 | 0.82 | POLB (0.43) | KMT2AMEN1POLBKDM4ECA1 | |
| SCHEMBL9818023 | 0.80 | ALDH1A1 (0.47) | KMT2AMEN1POLBKDM4EFAAH | |
| SCHEMBL8077162 | 0.80 | ALDH1A1 (0.47) | KMT2AMEN1POLBKDM4EFAAH | |
| SCHEMBL8021632 | 0.80 | ALDH1A1 (0.47) | KMT2AMEN1POLBKDM4EFAAH | |
| SCHEMBL1467675 | 0.77 | POLB (0.44) | KMT2AMEN1POLBKDM4EHEXA | |
| SCHEMBL14325520 | 0.77 | MGLL (0.42) | KMT2AMEN1POLBMGLLHPGD | |
| Ethylene Glycol SCHEMBL3521345 | 0.77 | ALDH1A1 (0.48) | KMT2AMEN1POLBKDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 606 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116917446-B | Hydroprocessing process using catalyst sequences with nickel, molybdenum and tungsten based catalysts | IFP Energies Nouvelles (FR) | 2026-05-26 | — | — | CN | claimed |
| US-12629669-B2 | Method for rejuvenating a catalyst from a hydroprocessing and/or hydrocracking process | IFP Energies Nouvelles (FR) | 2026-05-19 | — | — | US | claimed |
| EP-4558588-B1 | HYDROTREATMENT PROCESS USING A SEQUENCE OF CATALYSTS WITH A CATALYST BASED ON NICKEL AND TUNGSTEN ON A SILICA-ALUMINA SUPPORT | IFP ENERGIES NOW (FR) | 2026-05-13 | — | — | EP | claimed |
| US-12590254-B2 | Method for hydrodesulfurisation of a petroleum fraction using a catalyst containing a graphitic material characterised by the H/C ratio thereof | IFP Energies Nouvelles (FR) | 2026-03-31 | — | — | US | claimed |
| US-12521702-B2 | Trimetallic catalyst made from nickel, molybdenum and tungsten and use thereof in a hydrotreatment and/or hydrocracking process | IFP Energies Nouvelles (FR) | 2026-01-13 | — | — | US | claimed |
| EP-4251712-B1 | METHOD FOR HYDRODESULFURISATION OF A PETROLEUM FRACTION USING A CATALYST CONTAINING A GRAPHITIC MATERIAL CHARACTERISED BY THE H/C RATIO THEREOF | IFP ENERGIES NOW (FR) | 2026-01-07 | — | — | EP | claimed |
| US-20250361181-A1 | DEGRADED AMINE SOLUTION AS PERFORMANCE ENHANCER | HSUSTAINABILITY GMBH (DE) | 2025-11-27 | — | — | US | claimed |
| US-12467003-B2 | Hydrotreating process using a sequence of catalyst with a catalyst based on nickel, molybdenum and tungsten | IFP Energies Nouvelles (FR) | 2025-11-11 | — | — | US | claimed |
| WO-2025132026-A1 | PROCESS FOR PREPARING DIROXIMEL FUMARATE | SYNTHON B.V (NL) | 2025-06-26 | — | — | WO | claimed |
| EP-4565543-A1 | DEGRADED AMINE SOLUTION AS PERFORMANCE ENHANCER | Heidelberg Materials AG (DE) | 2025-06-11 | — | — | EP | claimed |
| WO-2003006599-A1 | MICROELECTRONIC CLEANING COMPOSITIONS CONTAINING AMMONIA-FREE FLUORIDE SALTS | MALLINCKRODT BAKER INC. (US) | 2003-01-23 | — | — | WO | claimed |
| WO-2003006598-A1 | AMMONIA-FREE ALKALINE MICROELECTRONIC CLEANING COMPOSITIONS WITH IMPROVED SUBSTRATE COMPATIBILITY | MALLINCKRODT BAKER INC. (US) | 2003-01-23 | — | — | WO | claimed |
| EP-0974557-B1 | Method for forming article using sol-gel processing | LUCENT TECHNOLOGIES INC (US) | 2002-10-02 | — | — | EP | claimed |
| EP-0796844-B1 | Process for the production of cyclic n-vinyl carboxylic acid amides | NIPPON CATALYTIC CHEM IND (JP) | 2001-05-16 | — | — | EP | claimed |
| US-6209357-B1 | AGING A SILICA DISPERSION WITH TETRAALKYLAMMONIUM HYDROXYDE STABILIZING AGENT,ADJUSTING THE ISOELECTRIC POINT TO9.0 OR HIGHER BY ADDING AMMONIUM HYDROXIDE OR AMINES;INDUCING GELATION AND DRYING;SILICA BODY OPTICAL FIBER PREFORM | LUCENT TECHNOLOGIES INC. | 2001-04-03 | — | — | US | claimed |
| EP-0974557-A1 | Method for forming article using sol-gel processing | LUCENT TECHNOLOGIES INC. (US) | 2000-01-26 | — | — | EP | claimed |
| EP-0678503-B1 | Delta-amino-gamma-hydroxy-omega-aryl alkanoic acid amides with enzyme especially renin inhibiting activities | NOVARTIS AG (CH) | 1999-09-01 | — | — | EP | claimed |
| US-5801252-A | Process for production of cyclic N-vinyl carboxylic acid amide | NIPPON SHOKUBAI CO., LTD. (JP) | 1998-09-01 | — | — | US | claimed |
| EP-0796844-A1 | Process for production of cyclic n-vinyl carboxylic acid amide | NIPPON SHOKUBAI CO., LTD. (JP) | 1997-09-24 | — | — | EP | claimed |
| US-4587050-A | Substituted enantholactam derivatives as antihypertensives | MERCK & CO., INC. (US) | 1986-05-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12590254-B2 | Method for hydrodesulfurisation of a petroleum fraction using a catalyst containing a graphitic material characterised by the H/C ratio thereof | HMOX2, SCO2, HAO2 | KMT2A 3494/4885MEN1 2274/4885POLB 1775/4885 |
| US-12629669-B2 | Method for rejuvenating a catalyst from a hydroprocessing and/or hydrocracking process | HOGA1, GK, PCK2 | KMT2A 2571/4885MEN1 1849/4885POLB 72/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.